Apolipoprotein E peptide stimulation of rat ovarian theca cell androgen synthesis is mediated by members of the low density lipoprotein receptor superfamily

Biology of Reproduction

Volumn 61, Issue 3, 1999, Pages 665-672

  Zerbinatti, Celina V ^a   Dyer, Cheryl A ^a  

^a NORTHERN ARIZONA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; APOLIPOPROTEIN E; HEPARIN LYASE; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEOHEPARAN SULFATE;

ANDROGEN SYNTHESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; FEMALE; NONHUMAN; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE MATURATION; PRIORITY JOURNAL; PROTEIN BINDING; RAT; THECA CELL;

AMINO ACID SEQUENCE; ANDROGENS; ANDROSTENEDIONE; ANIMALS; APOLIPOPROTEINS E; CELL COUNT; FEMALE; GLYCOSYLPHOSPHATIDYLINOSITOLS; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HEPARIN LYASE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LDL; RECOMBINANT PROTEINS; THECA CELLS;

ANIMALIA;

EID: 0032807501     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod61.3.665     Document Type: Article

References (45)

1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240:622-630.
2. Reyland ME. Gwynne JT, Forgez P, Prack MM, Williams DL. Expression of the human apolipoprotein E gene suppresses steroidogenesis in mouse Y1 adrenal cells. Proc Natl Acad Sci USA 1991; 88: 2375-2379.
3. Dyer CA, Curtiss LK. Apoprotein E-rich high density lipoproteins inhibit ovarian androgen synthesis. J Biol Chem 1988; 263:10965-10973.
4. Dyer CA, Smith RS, Curtiss LK. Only multimers of a synthetic peptide of human apolipoprotein E are biologically active. J Biol Chem 1991; 266:15009-15015.
5. Dyer CA, Curtiss LK. A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor. J Biol Chem 1991; 266:22803-22806.
6. Dyer CA, Cistola DP, Parry GC, Curtiss LK. Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor. J Lipid Res 1995; 36:80-88.
7. Zhang G, Curtiss LK, Wade RL, Dyer CA. An apolipoprotein E synthetic peptide selectively modulates the transcription of the gene for rat ovarian theca and interstitial cell P450 17 alpha-hydroxylase, C17-20 lyase. J Lipid Res 1998; 39:2406-2414.
8. Schneider WJ, Nimpf J, Bujo H. Novel members of the low density lipoprotein receptor superfamily and their potential roles in lipid metabolism. Curr Opin Lipidol 1997; 5:315-319.
9. Nikoulin IR, Curtiss LK. An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo. J Clin Invest 1998; 101:223-234.
10. Ji Z-S, Brecht WJ, Miranda RD, Hussain MM, Innerarity TI, Mahley RW. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem 1993; 268:10160-10167.
11. 125I-human chorionic gonadotropin binding to luteinizing hormone receptors in cultured immature Leydig cells is mediated by binding to heparan sulfate proteoglycans. Mol Cell Endocrinol 1993; 97:109-114.
12. Laslett AL, McFarlane JR, Hearn MTW, Risbridger GP. Requirement for heparan sulfate proteoglycans to mediate basic fibroblast growth factor (FGF-2)-induced stimulation of Leydig cell steroidogenesis. J Steroid Biochem Mol Biol 1995; 54:245-250.
13. Bu G. Receptor-associated protein: a specialized chaperone and antagonist for members of the LDL receptor gene family. Curr Opin Lipidol 1998; 9:149-155.
14. Ji Z-S, Dichek HL, Miranda RD, Mahley RW. Heparan sulfate proteoglycans participate in hepatic lipase and apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J Biol Chem 1997; 272:31285-31292.
15. Williams KJ, Fuki IV. Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism. Curr Opin Lipidol 1997; 8:253-262.
16. Al-Haideri M, Goldberg IJ, Galeano NF, Gleeson A, Vogel T, Gorecki M, Sturley SL, Deckelbaum RJ. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations. Biochemistry 1997; 36:12766-12772.
17. David G. Integral membrane heparan sulfate proteoglycans. FASEB J 1993; 7:1023-1030.
18. Weisgraber KH, Rall SC, Mahley RW, Milne RW, Marcel YL, Sparrow JT. Human apolipoprotein E: determination of the heparin binding sites of apolipoprotein E3. J Biol Chem 1986; 261:2068-2076.
19. Goldstein JL, Basu Sk, Brunschede GY, Brown MS. Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans. Cell 1976; 7:85-95.
20. Weisgraber KH. Apolipoprotein E: structure-function relationships. Adv Protein Chem 1994; 45:249-302.
21. Olsson U, Camejo G, Hurt-Camejo E, Elfsber K, Wiklund O, Bondjers G. Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the apo B/E receptor. Arterioscler Thromb Vasc Biol 1997; 17:149-155.
22. Ji Z-S, Fazio S, Mahley RW. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. J Biol Chem 1994; 269:13421-13428.
23. Vogel T, Guo N-H, Guy R, Drezlich N, Krutzsch HC, Blake DA, Danet A, Roberts DD. Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Biochem 1994; 54:299-308.
24. Lilly-Stauderman M, Brown TL, Balasubramaniam A, Harmony JAK. Heparin releases newly synthesized cell surface-associated apolipoprotein E from HepG2 cells. J Lipid Res 1993; 34:190-200.
25. Hurwitz A, Hernandez ER, Resnick CE, Packman JN, Payne DW, Adashi EY. Basic fibroblast growth factor inhibits gonadotropin-supported ovarian androgen biosynthesis: mechanism(s) and site(s) of action. Endocrinology 1990; 126:3089-3095.
26. Zachow RJ, Weitsman SR, Magoffin DA. Hepatocyte growth factor regulates ovarian theca-interstitial cell differentiation and androgen production. Endocrinology 1997; 138:691-697.
27. Sakata H, Stahl SJ, Taylor WG, Rosenberg JM, Sakaguch K, Wingfiedl PT, Rubin JS. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. J Biol Chem 1997; 272:9457-9463.
28. Nicosia M, Moger WH, Dyer CA, Prack MM, Williams DL. Apolipoprotein E messenger RNA in rat ovary is expressed in theca and interstitial cells and presumptive macrophage, but not in granulosa cells. Mol Endocrinol 1992; 6:978-988.
29. Polacek D, Beckman MW, Schreiber JR. Rat ovarian apolipoprotein E: localization and gonadotropin control of mRNA. Biol Reprod 1992; 46:65-72.
30. Jacobsen L, Madsen P, Moestrup SK, Lund AH, Tommerup N, Nykjaer A, Sottrup-Jensen L, Gliemann J, Petersen CM. Molecular characterization of a novel human hybrid-type receptor that binds the α2-macroglobulin receptor-associated protein. J Biol Chem 1996; 271: 31379-31383.
31. Jokinen EV, Landschulz KT, Wyne KL, Ho YK, Frykman PK, Hobbs HH. Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J Biol Chem 1994; 269:26411-26418.
32. Gliemann J. Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands. Biol Chem 1998; 379:951-964.
33. Goretzki L, Mueller BM. Receptor-mediated endocytosis of urokinase-type plasminogen activator is regulated by cAMP-dependent protein kinase. J Cell Sci 1997; 110:1395-1402.
34. Hjalm G, Murray E, Crumley G, Harazim W, Lundgren S, Onyango I, Ek B, Larsson M, Juhlin C, Hellman P, Davis H, Akerstrom G, Rask L, Morse B. Cloning and sequencing of human gp330, a Ca(2+)-binding receptor with potential intracellular signaling properties. Eur J Biochem 1996; 239:132-137.
35. Braw RH, Bar-Ami S, Tsafriri A. Effect of hypophysectomy on atresia of rat preovulatory follicles. Biol Reprod 1981; 25:989-996.
36. Uilenbroek JTJ, van der Schoot P, Woutersen PJA. Changes in steroidogenic activity of preovulatory rat follicles after blockage of ovulation with nembutal. In: Schwartz NB, Hunzicker-Dunn M (eds.), Dynamics of Ovarian Function. New York: Raven Press; 1981: 41-46.
37. Otsuka M, Kishi H, Arai K, Watanabe G, Taya K, Greenwald GS. Temporal changes in inhibin, steroid hormones and steroidogenic enzymes during induced follicular atresia in the hypophysectomized hamster. Biol Reprod 1997; 56:423-429.
38. McNatty KP, Lun S, Heath DA, Kieboom LE, Henderson KM. Influence of follicular atresia on LH-induced cAMP and steroid synthesis by bovine thecae interna. Mol Cell Endocrinol 1985; 39:209-215.
39. 17α in rat and guinea-pig gonads, adrenal glands and brain. J Reprod Fertil 1991; 93:609-622.
40. Billing H, Furata I, Hsueh AJW. Estrogens inhibit and androgen enhance ovarian granulosa cell apoptosis. Endocrinology 1993; 133: 2204-2212.
41. Dyer CA, Curtiss LK, Zerbinatti CV. Apolipoprotein E peptide modulates ovarian cell steroidogenesis via its direct interaction with protein kinase C. Circulation 1998; (suppl I):I-252 (Abstract #1309).
42. Mazzone T. Apolipoprotein E secretion by macrophages: its potential physiological functions. Curr Opin Lipidol 1996; 7:303-307.
43. Wang X, Gruenstein E. Rapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptide. J Cell Physiol 1997; 173:73-83.
44. Wang X, Luebbe P, Gruenstein E, Zemlan F. Apolipoprotein E (apo E) peptide regulates tau phosphorylation via two different signaling pathways. J Neurosci Res 1998; 51:658-665.
45. Wang X, Ciraolo G, Morris R, Gruenstein E. Identification of a neuronal endocytic pathway activated by an apolipoprotein E (apo E) receptor binding peptide. Brain Res 1997; 778:6-15.